A letter from the division co-directors
Cognition and emotion are the fundamental building blocks of human behavior. Our division brings together faculty with expertise in understanding and treating the complex illnesses that arise when cognition (how we think, remember, and sense) and emotion (what and how we feel) are disrupted and/or go out of control.
We are in the midst of a national search for our inaugural director for this division and look forward to announcing this news in the near future.
Our division members improve the lives of our patients, enhance teaching and modeling for our learners and bring forth new knowledge through innovative research and clinical care:
- Implementing and disseminating evidence-based treatments
- Developing, testing and validating new treatments
- Conducting basic, translational and clinical research
As we pursue the goals of our division, our work is sustained by building relationships, mutual support and mentorship opportunities.
Nicholas Breitborde, PhD, ABPP
Professor and Vice Chair for Academic Affairs, Department of Psychiatry and Behavioral Health
Director, Early Psychosis Intervention Center (EPICENTER)
Co-Director, Division of Cognition and Emotion
Jay Fournier, PhD
Associate Professor, Department of Psychiatry and Behavioral Health
Director, Mood and Anxiety Program
Co-Director, Division of Cognition and Emotion
The Division of Cognition and Emotion focuses on promoting positive cognition and positive emotion through clinical and research innovation.
- Specialized and individualized treatment for treatment-resistant depression including electroconvulsive therapy (ECT), transcranial magnetic stimulation (TMS), intravenous and intranasal ketamine, and other pharmacological treatment options under investigation in clinical trials.
- Specialized and individualized treatment for early psychosis including cognitive behavioral therapy, metacognitive remediation therapy, family education and support, medication therapies such as clozapine, and novel treatment options under investigation in clinical trials.
- Innovative treatments for attention deficit hyperactivity disorder including brain-based biofeedback.
- Neuroimaging research on anxiety and depression using functional magnetic resonance imaging (fMRI), electroencephalography (EEG) and electromyography (EMG) to better understand the brain basis of disease and mechanisms and predictors of treatment response.
- Comprehensive patient care and training: Multidisciplinary teams of specialists, including social workers, nurses, counselors, therapists, allied health professionals, psychologists and physicians, work together to create patient-centered treatment plans and develop expanded training opportunities throughout the division at the graduate, intern and postgraduate level, including students, residents and fellows.
Division Programs and Clinical Research
- Early Psychosis Intervention Center (EPICENTER): A multidisciplinary team of providers offers specialized care for individuals with first-episode psychosis and those at clinical high risk for developing a future psychotic disorder. Our current research mission focuses on the development and dissemination of new and novel treatments for psychosis as well as expanding our understanding of the mechanisms that shape the course of psychotic disorders.
- Mood and Anxiety Program: Our multidisciplinary team specializes in the treatment of depression, bipolar disorder and anxiety disorders and offers several evidence-based treatments such as cognitive behavioral therapy, mindfulness-based cognitive therapy and medication treatments
- Treatment Resistant Depression Program: Our services are dedicated to patients with depression who have not responded to first- and second-line treatments and span inpatient and outpatient settings to offer electroconvulsive therapy (ECT), transcranial magnetic stimulation (TMS), and intravenous and intranasal ketamine.
- Interventional Psychiatry Service: Our team delivers state-of-the-science neuromodulation treatments for depression and obsessive-compulsive disorder such as electroconvulsive therapy (ECT) and transcranial magnetic stimulation (TMS) and works with neurosurgeons to deliver deep brain stimulation (DBS).
- Women’s Behavioral Health Program: Multidisciplinary and comprehensive behavioral health care for mood and anxiety disorders, sexual health, substance use disorders and stress in women as they experience difficulties with unique life events, including pregnancy, the postpartum period, the menstrual cycle, and menopause. The Program supports women in coping with issues such as infertility and women’s cancers.
- Neurobehavioral Health Service: Clinicians and teaching faculty provide comprehensive assessments, consultation and empirically supported interventions for individuals with behavioral and cognitive symptoms arising from neurological and neuropsychiatric disorders such as dementia.
Cognition and Emotion Leadership
- Early Psychosis Intervention (EPICENTER): Nicholas Breitborde, PhD, ABPP
- Mood and Anxiety Program: Jay Fournier, PhD
- Treatment Resistant Depression Program: Subhdeep Virk, MD
- Interventional Psychiatry Service: Kevin Reeves, MD
- Women’s Behavioral Health Program: Kristen Carpenter, PhD
- Neurobehavioral Health Service: Kate Brownlowe, MD and Erica Dawson, PhD
Division News, Publications and Activities
- “Deep Brain Stimulation for Obsessive-Compulsive Disorder”
- “Sexuality, Fertility, and Cancer”
- “Depression Comorbid with Stroke, Traumatic Brain Injury Parkinson’s Disease, and Multiple Sclerosis.”
- “The Ohio State University Early Psychosis Intervention Center (EPICENTER) Step-Based Care Programme for Individuals at Clinical High Risk for Psychosis.”
- “Emotion-based brain mechanisms and predictors for SSRI and CBT treatment of anxiety and depression: a randomized trial.”
- "Neural function during emotion regulation and future depressive symptoms in youth at risk for affective disorders."